Belpointe Asset Management LLC Makes New Investment in Haleon plc (NYSE:HLN)

Belpointe Asset Management LLC acquired a new stake in shares of Haleon plc (NYSE:HLN – Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 10,753 shares of the company’s stock, valued at approximately $86,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Keystone Financial Group lifted its holdings in shares of Haleon by 5.8% in the fourth quarter. Keystone Financial Group now owns 23,460 shares of the company’s stock worth $188,000 after buying an additional 1,278 shares in the last quarter. Comerica Bank grew its position in shares of Haleon by 1.8% during the fourth quarter. Comerica Bank now owns 109,289 shares of the company’s stock valued at $891,000 after purchasing an additional 1,906 shares in the last quarter. Kestra Private Wealth Services LLC increased its holdings in shares of Haleon by 27.1% in the fourth quarter. Kestra Private Wealth Services LLC now owns 12,797 shares of the company’s stock worth $102,000 after purchasing an additional 2,730 shares during the last quarter. Lindbrook Capital LLC lifted its position in shares of Haleon by 76.1% in the fourth quarter. Lindbrook Capital LLC now owns 6,671 shares of the company’s stock worth $53,000 after buying an additional 2,882 shares in the last quarter. Finally, Tompkins Financial Corp bought a new position in Haleon during the fourth quarter valued at approximately $31,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HLN has been the topic of a number of research reports. Investec initiated coverage on Haleon in a report on Thursday, February 23rd. They set a “sell” rating on the stock. Barclays lifted their price objective on shares of Haleon from GBX 360 ($4.51) to GBX 364 ($4.56) in a research note on Tuesday, January 31st. Sanford C. Bernstein started coverage on shares of Haleon in a research report on Tuesday, April 4th. They set an “outperform” rating on the stock. Finally, Argus raised Haleon from a “hold” rating to a “buy” rating in a research report on Thursday, April 6th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Haleon currently has a consensus rating of “Hold” and an average price target of $364.00.

Haleon Price Performance

Shares of HLN stock opened at $8.65 on Friday. The stock has a 50 day moving average price of $8.55 and a 200 day moving average price of $7.93. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.93 and a quick ratio of 0.62. Haleon plc has a 52-week low of $5.59 and a 52-week high of $9.05.

Haleon Dividend Announcement

The business also recently announced a — dividend, which was paid on Thursday, April 27th. Stockholders of record on Friday, March 17th were paid a dividend of $0.0577 per share. This represents a dividend yield of 0.7%. The ex-dividend date of this dividend was Thursday, March 16th.

About Haleon

(Get Rating)

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.